Glenmark Pharmaceuticals Ltd
BSE:532296
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glenmark Pharmaceuticals Ltd
BSE:532296
|
IN |
|
BayWa AG
LSE:0AH6
|
DE |
|
Dynamatic Technologies Ltd
NSE:DYNAMATECH
|
IN |
Dividends
Dividend Yield
Glenmark Pharmaceuticals Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Glenmark Pharmaceuticals Ltd
Payout Ratio
Glenmark Pharmaceuticals Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for GLENMARK is .
Peers Comparison
Shareholder Yield
Price Appreciation
GLENMARK Price
Glenmark Pharmaceuticals Ltd
| Average Annual Return | 39.82% |
| Standard Deviation of Annual Returns | 63.68% |
| Max Drawdown | -49% |
| Market Capitalization | 660.5B INR |
| Shares Outstanding | 282 220 300 |
| Percentage of Shares Shorted |
N/A
|
GLENMARK Return Decomposition
Main factors of price return
Stock Splits
GLENMARK's latest stock split occurred on Sep 10, 2007
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
The adjusted shares began trading on Sep 10, 2007. This was stock split number 3 in GLENMARK's history, following the previous one in Mar 4, 2005.